Can large, simple trials bring drug developers back to common diseases?

IF 122.7 1区医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Nature Reviews. Drug Discovery Pub Date : 2025-02-18 DOI:10.1038/d41573-025-00030-0

Asher Mullard

引用次数: 0

Abstract

Clinical trials for common diseases can be done much more cheaply, says Martin Landray, a physician and epidemiologist at Oxford University and CEO of Protas, a non-profit clinical trial organization. Clinical trials for common diseases can be done much more cheaply, says Martin Landray, a physician and epidemiologist at Oxford University and CEO of Protas, a non-profit clinical trial organization.

Abstract Image

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews. Drug Discovery 医学-生物工程与应用微生物

CiteScore

137.40

自引率

0.30%

发文量

227

期刊介绍： Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. Each issue includes: Highest-quality reviews and perspectives covering a broad scope. News stories investigating the hottest topics in drug discovery. Timely summaries of key primary research papers. Concise updates on the latest advances in areas such as new drug approvals, patent law, and emerging industry trends and strategies.